Research and Markets: Global Transdermal Patch Market & Pipeline Insight 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/qr543d/global) has announced the addition of the "Global Transdermal Patch Market & Pipeline Insight 2015" report to their offering.

Clinical pipeline for transdermal patches is becoming strong and various novel therapeutics are at different stages of clinical trials which would enter in market in coming years. It is happening because pharmaceutical companies have identified their commercial potential due to which they are investing more toward research and development segment.

Orally administrated drugs are not suitable for all patients as they have gastric reflex problem or may have other gastrointestinal diseases due to which bioavailability is limited. On the other, in blood they may interact with other substance causing reduced pharmacological effects. All these problems are not encountered by patients using the transdermal patches.

New principles are being deciphered and increasing emphasis on including more diseases treatment by transdermal patches is imperative for better health. Owing to increasing disease incidences, it has become necessary to take necessary steps to introduce innovative transdermal patches in global market. Oncology and autoimmune diseases are still untouched by them due to which significant opportunities are left untapped. Technological advancements may allow the investigators to develop products having high safety and efficacy levels along with minimized side effects but it will take some time.

On the other hand, nicotine patches and female contraceptive patches are highly developed and forms largest categories of transdermal patch segment. Disease indications will be increased in coming years and advancements in polymer science is expected to increase the innovation rates. With all these developments, the future of transdermal patch market seems to be optimistic.

Global Transdermal Patch Market & Pipeline Insight 2015 Report Highlights:

- Mechanism of Transdermal Patch Drug Delivery

- Global Transdermal Patch Market Outlook

- Transdermal Patch Clinical Pipeline by Company, Indication & Phase

- Transdermal Patches in Clinical Pipeline: 93

- Marketed Transdermal Patches: 51

- Global Transdermal Patch Market Future Prospects

Companies Mentioned

- 3M Pharmaceuticals

- Actavis

- Ethical Holdings

- GalaxoSmithKline

- Johnson & Johnson

- Novartis

- Pfizer

- ProStrakan

- Proctor & Gamble

- UCB pharmaceuticals

- Vaxxas pharmaceutical

For more information visit http://www.researchandmarkets.com/research/qr543d/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices